News and Updates:
June 5 2024 – Azemiglitazone GLP1 Lean Muscle Benefit EASL

Cirius Therapeutics is a clinical-stage pharmaceutical company developing innovative therapies for diseases caused by insulin resistance including Type 2 Diabetes, the metabolic consequences of Obesity, and MASLD/MASH